Cargando…
Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer
Cell-free DNA (cfDNA) has recently emerged as a real-time biomarker for diagnosis, monitoring and prediction of therapy response in tumoral disease. Here, we evaluated cfDNA as a prognostic biomarker for monitoring muscle-invasive bladder cancer (MIBC) patients at different follow-up time points. Bl...
Autores principales: | Carrasco, Raquel, Ingelmo-Torres, Mercedes, Gómez, Ascensión, Trullas, Ramón, Roldán, Fiorella L., Ajami, Tarek, Moreno, Davinia, Rodríguez-Carunchio, Leonardo, Alcaraz, Antonio, Izquierdo, Laura, Mengual, Lourdes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570339/ https://www.ncbi.nlm.nih.gov/pubmed/36233035 http://dx.doi.org/10.3390/ijms231911732 |
Ejemplares similares
-
Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer
por: Carrasco, Raquel, et al.
Publicado: (2022) -
Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma
por: Roldán, Fiorella L., et al.
Publicado: (2022) -
Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication
por: Carrasco, Raquel, et al.
Publicado: (2021) -
Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma
por: Roldán, Fiorella L., et al.
Publicado: (2021) -
Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer
por: Ingelmo-Torres, Mercedes, et al.
Publicado: (2017)